We first knocked down parkin by specific shRNA in SH-SY5Y cells, a neuroblastoma cell line that expresses endogenous parkin, and found that there was an accumulation of p62 when parkin was knocked down (Figs. 2A and S2). The gene discussed is PRKN; the disease is neuroblastoma.